Saturday 17 October 2026
Export IMA’s income statement to Excel — free account
ImageneBio, Inc.
ImageneBio, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $800,000.00, down 77.1% from fiscal 2024. In the quarter to June 2026, revenue fell 60.1%, EPS grew 12.5% and free cash flow grew 23.8%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
4.04
0.01
+0.25%
Follow IMA
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (41.34%) | (44.61%) | 225.87% | (42.19%) |
+8 more TTM periods Free account |
|
| (38.34%) | (40.29%) | (62.04%) | (37.32%) | ||
ROIC |
(622.37%) | (557.03%) | 0.00% | 0.00% | |
Return on Tangible Assets |
(39.64%) | (46.71%) | (40.60%) | (42.39%) | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(3.25) | (4.94) | (9.82) | (5.17) | |
Free Cash Flow |
(52.59) | (55.41) | (47.84) | (44.10) | |
| Other line items | |||||
Cash ROIC |
(18.90%) | (23.04%) | (17.82%) | (15.62%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.01) | (0.01) | (0.01) | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Operating CF/Net income |
0.99 | 1.03 | 0.91 | 0.76 | |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(3.25) | (4.94) | (9.82) | (5.17) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates